Mum-of-five wins competition to become a millionaire on live radio show
Shelley Humphries previously turned down a £10k prize in order to be in the running for the £1million prize
Updated
The video will auto-play soon8Cancel
Play now
There are always big stories on WalesOnline - don t miss any with our daily emailInvalid EmailSomething went wrong, please try again later.
Sign me up now
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
E-Mail
Scientists from the Wellcome Sanger Institute and the University of Cambridge found that in children with neuroblastoma - a cancer of immature nerve cells - treatment with platinum chemotherapy caused changes to the genome that could then cause leukaemia in some children later on.
The findings, published 27th May 2021 in
Blood could lead to an ability to identify which children are more likely to develop the secondary cancer. This in turn could lead to changes in their treatment plan to either avoid these risks or take measures to prepare.
Secondary blood cancer is a challenging complication of childhood neuroblastoma cancer treatment. Every year around 100 children in the UK are diagnosed with neuroblastoma , and those who had high-risk treatment are at an increased risk of developing secondary blood cancer - leukaemia - after neuroblastoma treatment.